NovoBind is an animal health company using a proven biologics platform to develop precision biologics (NBXs) which are antimicrobial applications against bacteria, viruses and parasites in animals. NovoBind solutions are being developed for inclusion in standard feed for terrestrial and aquaculture applications. NBXs are naturally sourced, biologically produced, non-GMOs, that specifically target and neutralize “bad actors”. NovoBind’s developmental NBXs currently target pathogens which cause an aggregate annual loss of USD $22 billion to poultry, shrimp and companion animal sectors.